Patents by Inventor Patrick J. Cassidy

Patrick J. Cassidy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6277425
    Abstract: An apparatus and method for manufacturing an extruded cooked food product including use of an extruder having a barrel, at least one screw contained therein, a feed element at the discharge end of the screw, and a die head containing an expansion chamber. The discharge feed element is formed with a large pitch for pushing a large volume of cooked food mix into the expansion chamber. The large volume of cooked food mix is extruded as extrudate strands through relatively large orifices extending through the die plate of the die head to dimensionally expand upon exiting the orifices. The extrudate strands are conveyed over a sole support bar located a significant distance from the die head and then to a cutter. An air flow is applied to the extrudate strands for further cooling and drying before being cut. The cutter is located approximately 90 inches from the die head. The extruded food product is uniform in cross-section.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: August 21, 2001
    Assignee: Good Mark Foods, Inc.
    Inventors: J. Barry Nash, Salvatore M. Pileggi, Patrick J. Cassidy, Richard R. Hawkins, Jonathan Bosworth
  • Patent number: 4304859
    Abstract: There is disclosed a new antibiotic agent, A73A, produced by Streptomyces viridifaciens MA-4864 (ATCC 31495) under suitable conditions. Said antibiotic shows antibacterial and growth-permittant activity.
    Type: Grant
    Filed: October 27, 1980
    Date of Patent: December 8, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Ray S. Dewey, James E. Flor, Sheldon B. Zimmerman, Patrick J. Cassidy, Satoshi Omura, Ruiko Oiwa
  • Patent number: 4264736
    Abstract: The antibiotic MSD 890A.sub.10 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotic 890A.sub.10) is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: September 26, 1979
    Date of Patent: April 28, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Sheldon B. Zimmerman, Josefino B. Tunac, Sebastian Hernandez
  • Patent number: 4264735
    Abstract: The antibiotic MSD 890A.sub.9 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotic 890A.sub.9) is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: September 10, 1979
    Date of Patent: April 28, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Sheldon B. Zimmerman, Josefino B. Tunac, Sebastian Hernandez
  • Patent number: 4262002
    Abstract: There is disclosed a new antibiotic agent, A73A, produced by Streptomyces viridifaciens MA-4864 (ATCC 31495) under suitable conditions. Said antibiotic shows antibacterial and growth-permittant activity.
    Type: Grant
    Filed: June 22, 1979
    Date of Patent: April 14, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Ray S. Dewey, James E. Flor, Sheldon B. Zimmerman, Patrick J. Cassidy, Satoshi Omura, Ruiko Oiwa
  • Patent number: 4235967
    Abstract: The antibiotics MSD 890A.sub.1 and MSD 890A.sub.3 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.1 and 890A.sub.3) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: April 6, 1979
    Date of Patent: November 25, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
  • Patent number: 4207395
    Abstract: Disclosed is a process for enzymatically cleaving the acyl group from N-acyl-6-substituted-2-substituted-1-carbadethiapen-2-em-3-carboxylic acids. The acylated substrate and the deacylated product are antibiotics.
    Type: Grant
    Filed: November 2, 1978
    Date of Patent: June 10, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Jean S. Kahan
  • Patent number: 4168202
    Abstract: The antibiotics MSD 890A.sub.2 and MSD 890A.sub.5 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.2 and 890A.sub.5) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: July 8, 1977
    Date of Patent: September 18, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
  • Patent number: 4162324
    Abstract: The antibiotics MSD 890A.sub.1 and MSD 890A.sub.3 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.1 and 890A.sub.3) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: August 25, 1977
    Date of Patent: July 24, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
  • Patent number: 4141986
    Abstract: The antibiotics MSD 890A.sub.2 and MSD 890A.sub.5 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.2 and 890A.sub.5) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: August 5, 1977
    Date of Patent: February 27, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez